A focus on dominant negative variants in a series of 170 heterozygous FXI-deficient patients
- PMID: 37252892
- DOI: 10.1111/hae.14802
A focus on dominant negative variants in a series of 170 heterozygous FXI-deficient patients
Abstract
Introduction: Dominant-negative effects have been described for 10 F11 variants in the literature.
Aim: The current study aimed at identifying putative dominant-negative F11 variants.
Material and methods: This research consisted in a retrospective analysis of routine laboratory data.
Results: In a series of 170 patients with moderate/mild factor XI (FXI) deficiencies, we identified heterozygous carriers of previously reported dominant-negative variants (p.Ser243Phe, p.Cys416Tyr, and p.Gly418Val) with FXI activities inconsistent with a dominant-negative effect. Our findings also do not support a dominant-negative effect of p.Gly418Ala. We also identified a set of patients carrying heterozygous variants, among which five out of 11 are novel, with FXI activities suggesting a dominant-negative effect (p.His53Tyr, p.Cys110Gly, p.Cys140Tyr, p.Glu245Lys, p.Trp246Cys, p.Glu315Lys, p.Ile421Thr, p.Trp425Cys, p.Glu565Lys, p.Thr593Met, and p.Trp617Ter). However, for all but two of these variants, individuals with close to half normal FXI coagulant activity (FXI:C) were identified, indicating an inconstant dominant effect.
Conclusion: Our data show that for some F11 variants recognized has having dominant-negative effects, such effects actually do not occur in many individuals. The present data suggest that for these patients, the intracellular quality control mechanisms eliminate the variant monomeric polypeptide before homodimer assembly, thereby allowing only the wild-type homodimer to assemble and resulting in half normal activities. In contrast, in patients with markedly decreased activities, some mutant polypeptides might escape this first quality control. In turn, assembly of heterodimeric molecules as well as mutant homodimers would result in activities closer to 1:4 of FXI:C normal range.
Keywords: F11 gene; F11 variant; FXI deficiency; HPO 0001928 Abnormality of coagulation; HPO 0003256 Abnormality of the coagulation cascade; dominant negative variant.
© 2023 The Authors. Haemophilia published by John Wiley & Sons Ltd.
Similar articles
-
Global epidemiology of factor XI deficiency: A targeted review of the literature and foundation reports.Haemophilia. 2023 Mar;29(2):423-434. doi: 10.1111/hae.14687. Epub 2022 Nov 11. Haemophilia. 2023. PMID: 36367760 Review.
-
[Analysis of a pedigree affected with hereditary coagulation factor XI deficiency due to compound heterozygous variants of F11 gene].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021 Mar 10;38(3):242-246. doi: 10.3760/cma.j.cn511374-20200123-00047. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021. PMID: 33751533 Chinese.
-
High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: Results from the Yecla study.Haemophilia. 2017 Nov;23(6):e488-e496. doi: 10.1111/hae.13356. Epub 2017 Sep 27. Haemophilia. 2017. PMID: 28960694
-
Factor 11 single-nucleotide variants in women with heavy menstrual bleeding.J Obstet Gynaecol. 2017 Oct;37(7):912-918. doi: 10.1080/01443615.2017.1312303. Epub 2017 Jun 13. J Obstet Gynaecol. 2017. PMID: 28609141 Review.
-
Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain.Blood. 2004 Jul 1;104(1):128-34. doi: 10.1182/blood-2003-10-3530. Epub 2004 Mar 16. Blood. 2004. PMID: 15026311
References
REFERENCES
-
- Asakai R, Davie EW, Chung DW. Organization of the gene for human factor XI. Biochemistry. 1987;26(23):7221-7228.
-
- Peyvandi F, Palla R, Menegatti M, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost. 2012;10(4):615-621.
-
- Gomez K, Bolton-Maggs P. Factor XI deficiency. Haemophilia. 2008;14(6):1183-1189.
-
- Veitia RA. Dominant negative factors in health and disease. J Pathol. 2009;218(4):409-418.
-
- Kravtsov DV, Wu W, Meijers JCM, et al. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood. 2004;104(1):128-134.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous